CareCloud Earnings Call Highlights Profits, AI Push

Carecloud, Inc. ((CCLD)) has held its Q4 earnings call. Read on for the main highlights of the call.

CareCloud’s latest earnings call struck a decidedly upbeat tone, with management emphasizing a rare combination of accelerating growth, expanding profitability and rising cash generation. Executives acknowledged pockets of risk around quarterly volatility, liquidity and integration of recent deals and AI products, but framed these as manageable against the backdrop of record results and a stronger balance sheet.

Revenue Growth Beats and Raised Targets

CareCloud delivered full-year 2025 revenue of $120.5 million, up about 9% year over year, capped by a strong fourth quarter at $34.4 million. Q4 revenue grew roughly 22% from a year earlier, and management reminded investors that they had raised guidance twice during 2025 and still finished ahead of their final revenue target.

First-Ever Full-Year Positive EPS Since IPO

Profitability took a notable step forward as GAAP net income reached $10.8 million in 2025, more than 37% higher than the prior year. That translated into GAAP earnings per share of $0.10, marking CareCloud’s first positive full-year EPS since its 2014 IPO, with Q4 EPS coming in at $0.04.

EBITDA Expansion Underscores Operating Leverage

Adjusted EBITDA rose to $27.5 million for 2025, reflecting more than 14% year-over-year growth and a solid 23% margin. In the fourth quarter, adjusted EBITDA was $7.7 million, or about 22% of revenue, showing that the company is maintaining margin discipline even as it invests in new products and integrations.

Cash Generation Accelerates, Fueling Growth

Operating cash flow for 2025 climbed to $28.6 million, up roughly 38% compared with the prior year, with Q4 cash from operations jumping about 66% to $8.7 million. Non-GAAP free cash flow reached approximately $20.5 million versus $13.2 million in 2024, a rise of about 55%, and management highlighted that free cash flow has grown more than fivefold since 2023.

Leaned-Up Capital Structure Reduces Fixed Burden

Management highlighted a cleaner capital structure after converting around 80% of Series A preferred shares, eliminating more than $7 million in annual dividend obligations. The company also fully repaid its credit line with Provident Bank, entering 2026 with that $10 million facility undrawn and a materially lower recurring cash burden.

Acquisitions Drive Scale Without Dilution

CareCloud completed four acquisitions in 2025, including Medsphere and MAP App, paying less than 1x revenue and funding the deals entirely from free cash flow. Medsphere alone contributed roughly $7.2 million of Q4 revenue and pushes CareCloud more deeply into inpatient and emergency department markets, broadening the company’s footprint beyond its traditional ambulatory base.

AI Suite Launches Show Early Commercial Traction

The company rolled out its stratusAI Front Desk Agent commercially in December 2025, alongside deployment of CirrusAI Notes and Voice Audit for clinical documentation and review. Management cited a customer example where the Front Desk Agent handled about 80% of inbound scheduling calls and pointed to a U.S. front-desk automation market they estimate at more than $4 billion.

Guidance Calls for Continued Growth and Margin Gains

CareCloud’s 2026 outlook calls for revenue of $128 million to $130 million, implying roughly 6% to 8% growth over 2025’s $120.5 million. The company projects adjusted EBITDA of $29 million to $31 million, indicating further margin expansion, and GAAP EPS of $0.20 to $0.23, more than double 2025 levels, while assuming capital spending remains flat to slightly lower and excluding any potential yet-unannounced acquisitions.

Short-Term Earnings Dip and Liquidity Constraints

Despite the strong full-year trajectory, Q4 2025 GAAP net income slipped to $2.9 million from $3.3 million a year earlier, underscoring some quarter-to-quarter volatility. Investors may also note that year-end cash stood at roughly $3.6 million and net working capital at about $1.3 million, leaving a relatively thin liquidity cushion even though the $10 million credit line remains available.

Integration, M&A Dependence and AI Market Risks

Management was candid that a meaningful slice of recent growth and 2026 cross-sell opportunity stems from acquisitions such as Medsphere and MAP App, making integration a key execution swing factor. They also flagged broader SaaS and AI market uncertainty, including regulatory and competitive pressures, and stressed that ongoing investment in AI R&D and automation is essential but not guaranteed to deliver returns on a fixed timeline.

CareCloud’s earnings call painted a picture of a company transitioning from a growth-at-any-cost model toward consistent profitability and cash generation, while leaning hard into AI and targeted acquisitions. For investors, the story is one of encouraging momentum with clear upside from cross-sell and automation, but also real execution and liquidity risks that will need to be monitored as 2026 unfolds.